“…Maintenance of HFS-LTP consists of at least two phases: an early, labile phase dependent on covalent modifications of existing proteins; and a late, stable phase requiring new mRNA and protein synthesis (Krug et al, 1984;Matthies et al, 1990;Bliss and Collingridge, 1993;Frey et al, 1996;Nguyen and Kandel, 1996). LTP maintenance is impaired by treatment with antibodies that inhibit activation of the BDNF receptor TrkB, or by deletion of the BDNF or TrkB genes (Figurov et al, 1996;Kang et al, 1997;Korte et al, 1998;Chen et al, 1999;Minichiello et al, 1999;Xu et al, 2000;Kossel et al, 2001;Patterson et al, 2001). Depending on the stimulation parameters used, relatively selective impairment in the ability to generate late, transcription-dependent LTP is seen (Kang et al, 1997;Korte et al, 1998;Minichiello et al, 1999;Patterson et al, 2001).…”